Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer

Eur J Surg. 1994 Sep;160(9):497-502.

Abstract

Objective: To evaluate the effect of extensive lymphadenectomy on survival in patients with gastric cancer.

Design: Retrospective analysis

Setting: University Hospital, Norway.

Subjects: 183 patients with stomach cancer resected for cure during the time period 1980-90.

Interventions: 78 patients had an R1- and 105 patients and R2 resection. 124 patients were treated by total gastrectomy, 5 by proximal--and 54 by distal resection.

Main outcome measures: Morbidity, mortality and long term survival.

Results: The morbidity was 33% (60/183), of which 39 (21%) were general complications (pneumonia, thrombosis, or cardiovascular disease). 14 patients died postoperatively (8%). By logistic regression analysis we found that splenectomy was the only variable associated with both morbidity and immediate postoperative mortality. Five year survival was 39% for patients who had undergone curative resections, 30% for patients who had had an R1 resection, and 47% for those who had had an R2 resection. By multivariate analysis (Cox) we found that N-classification (TNM), tumour diameter of less than 45 mm, type of lymph node dissection (R2) and operation period (after 1984) correlated with improved survival.

Conclusion: Extensive lymph node dissection improves survival without increasing morbidity or postoperative mortality.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Gastrectomy / adverse effects
  • Gastrectomy / methods*
  • Gastrectomy / mortality
  • Humans
  • Lymph Node Excision / adverse effects
  • Lymph Node Excision / methods*
  • Lymph Node Excision / mortality
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Postoperative Complications / mortality
  • Prognosis
  • Regression Analysis
  • Retrospective Studies
  • Splenectomy / adverse effects
  • Splenectomy / methods*
  • Splenectomy / mortality
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Survival Rate
  • Time Factors